FDA approved cancer treatment Lynparz (olaparib) treats various types of advanced ovarian cancers that contain a defective BRCA gene. In this video, medical oncologist Stephen Lemon MD discusses how this treatment works, as what types of side effects it may cause.
Lynparza is marketed by AstraZeneca Pharmaceuticals. Dr. Lemon is a medical oncologist who is not affiliated with AstraZeneca.